USANA HEALTH SCIENCES, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- USANA HEALTH SCIENCES, INC. payments for repurchase of common stock for the quarter ending 2026-07-04 was $0.00, a 100.00% decline year-over-year.
- USANA HEALTH SCIENCES, INC. payments for repurchase of common stock for the quarter ending 2026-04-04 was $0.00, a 100.00% decline year-over-year.
- USANA HEALTH SCIENCES, INC. payments for repurchase of common stock for the quarter ending 2026-01-03 was $0.00.
- USANA HEALTH SCIENCES, INC. payments for repurchase of common stock for the quarter ending 2025-09-27 was $0.00.
- USANA HEALTH SCIENCES, INC. payments for repurchase of common stock for fiscal 2026 was $27.51M, a 191.26% increase from fiscal 2024.
- USANA HEALTH SCIENCES, INC. payments for repurchase of common stock for fiscal 2024 was $9.44M, a 18.58% decline from fiscal 2023.
- USANA HEALTH SCIENCES, INC. payments for repurchase of common stock for fiscal 2023 was $11.60M, a 54.30% decline from fiscal 2022.
- USANA HEALTH SCIENCES, INC. payments for repurchase of common stock for fiscal 2022 was $25.38M, a 85.73% decline from fiscal 2022.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-07-04 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-04-04 | $0.00 10-Q · filed 2026-05-12 | $15.21M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-01-03 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $27.51M 10-K · filed 2026-03-16 |
| 2025-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $27.51M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-28 | $15.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $27.51M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-29 | $12.30M 10-Q · filed 2026-05-12 | $12.30M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $9.44M 10-K · filed 2026-03-16 |
| 2024-09-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $9.44M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $21.04M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-30 | $9.44M 10-Q · filed 2025-05-06 | $21.04M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $11.60M 10-K · filed 2026-03-16 |
| 2023-09-30 | $11.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $11.60M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-07-01 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $0.00 derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-04-01 | $0.00 10-Q · filed 2024-05-07 | $0.00 derived: sum of 4 quarters · filed 2025-03-12 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $25.38M 10-K · filed 2025-03-12 |
| 2022-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $57.29M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-07-02 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $104.06M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-04-02 | $25.38M 10-Q · filed 2023-05-09 | $135.61M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-01-01 | $31.91M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $177.84M 10-K · filed 2024-02-27 |
| 2021-10-02 | $46.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $145.93M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-07-03 | $31.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $99.16M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-04-03 | $67.61M 10-Q · filed 2022-05-11 | $67.61M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-01-02 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $57.03M 10-K · filed 2023-02-28 |
| 2020-09-26 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $57.03M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-27 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $149.41M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-28 | $57.03M 10-Q · filed 2021-05-11 | $177.03M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $150.00M 10-K · filed 2022-03-01 |
| 2019-09-28 | $92.38M 10-Q · filed 2020-11-03 | $229.78M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-06-29 | $27.62M 10-Q · filed 2019-08-06 | $160.06M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-03-30 | $30.00M 10-Q · filed 2020-05-05 | $132.43M derived: sum of 4 quarters · filed 2021-03-02 |
| 2018-12-29 | $79.78M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $105.38M 10-K · filed 2021-03-02 |
| 2018-09-29 | $22.65M 10-Q · filed 2019-11-05 | $25.59M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $52.94M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $2.94M 10-Q · filed 2019-05-07 | |
| 2017-12-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $50.00M 10-K · filed 2020-02-25 |
| 2017-09-30 | $50.00M 10-Q · filed 2018-11-07 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $64.61M 10-K · filed 2019-02-26 |
| 2016-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | |
| 2016-07-02 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | |
| 2016-04-02 | $64.61M 10-Q · filed 2017-05-10 | |
| 2016-01-02 | $61.18M 10-K · filed 2018-02-28 | |
| 2015-01-03 | $16.16M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $138.82M 10-K · filed 2017-03-01 |
| 2014-09-27 | $76.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | |
| 2013-12-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $18.09M 10-K · filed 2016-03-01 |
| 2013-09-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $50.88M derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-06-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $59.82M derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-03-30 | $18.09M 10-Q · filed 2014-05-07 | |
| 2012-12-29 | $32.79M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17 | $68.29M 10-K · filed 2015-03-17 |
| 2012-09-29 | $8.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | |
| 2011-12-31 | $758.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $33.46M 10-K · filed 2014-03-13 |
| 2011-10-01 | $7.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $41.10M derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-07-02 | $16.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | |
| 2011-04-02 | $8.52M 10-Q · filed 2012-05-10 | |
| 2011-01-01 | $8.40M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $17.03M 10-K · filed 2013-03-11 |
| 2010-01-02 | $1.65M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |